The landscape of dementia diagnosis has evolved dramatically with the arrival of subtle biomarkers, like amyloid PET scans, tau imaging, and blood-centered exams that could detect Alzheimer's pathology decades just before signs or symptoms arise. Whilst these technological improvements characterize outstanding progress in knowledge neurodegenerativ